Application of Claims-based Frailty Index to a Structured Electronic Health Record Data

将基于索赔数据的衰弱指数应用于结构化电子健康记录数据

阅读:2

Abstract

BACKGROUND: The Claims-based Frailty Index (CFI) has been developed and validated using Medicare claims data. However, whether CFI can be applied to structured electronic health record data has not been studied. METHODS: We applied the CFI to a structured electronic health record dataset (Explorys dataset) and a Medicare fee-for-service 5% sample data and compared the prevalence of frailty from each dataset, using the cohort of older adults. Then, we assessed the odds ratio and area under the curve of the frailty predicting adverse clinical outcomes, any hospital or emergency room visit, or any adverse drug events related encounter within 1 year in each dataset. RESULTS: A total of 526 681 from the Explorys dataset (64.6% with Medicare insurance [Explorys-Medicare], and 35.4% with non-Medicare insurance [Explorys-non-Medicare]) and 346 070 individuals from the Medicare dataset were included. The prevalence of frailty, defined as CFI ≥ 0.25, among heart failure patients was 7.4% in the Explorys-Medicare dataset, 7.1% in Explorys-non-Medicare, and 14.2% in the Medicare dataset. The odds ratios of frailty for any hospital or emergency room visit were 3.57, 4.37, and 3.76 in Explorys-Medicare, Explorys-non-Medicare, and Medicare datasets, and for any adverse drug event-related encounter, they were 2.61, 3.29, and 2.89, respectively. The area under the curve of the frailty index were 0.656, 0.676, and 0.697 for any hospital or emergency room visit and 0.654, 0.676, and 0.654 for any adverse drug event-related encounter, respectively. CONCLUSIONS: When the CFI was applied to a structured electronic health record dataset, it captured fewer frailty cases than the Medicare dataset but had similar performance in predicting adverse clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。